Myung Lee

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia

M. Territo, G. Schiller, Stephen S. Nimer, 1993, American journal of hematology.

A randomized study of intermediate versus conventional‐dose cytarabine as intensive induction for acute myelogenous leukaemia

M. Territo, G. Schiller, R. Champlin, 1992, British journal of haematology.

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non‐Hodgkin's lymphoma

B. Nathwani, A. Tulpule, G. Schiller, 1998, Cancer.

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

S. Nimer, M. Territo, G. Schiller, 1992 .

Threshold dose of autologous CD34-positive peripheral blood progenitor cells required for engraftment after myeloablative treatment for multiple myeloma

L. Rosen, G. Schiller, J. Berenson, 1994 .

Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma.

A. Lichtenstein, G. Schiller, J. Berenson, 1995, Blood.